These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1446080)

  • 21. Nucleolar organizer regions in superficial spreading melanoma with nodule.
    Albrecht S; Jambrosic JA; Kahn HJ
    Mod Pathol; 1989 Nov; 2(6):666-70. PubMed ID: 2587571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silver-stained nucleoli and nucleolar organizer region counts are of no prognostic value in thick cutaneous malignant melanoma.
    Howat AJ; Giri DD; Wright AL; Underwood JC
    J Pathol; 1988 Nov; 156(3):227-32. PubMed ID: 3204453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AgNOR (nucleolar organizer regions) staining in malignant melanoma.
    Nagatani T; Iemoto G; Miyakawa K; Ichiyama S; Takahashi Y; Uchiyama M; Nakajima H
    J Dermatol; 1991 Dec; 18(12):731-5. PubMed ID: 1806604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silver staining of nucleolar organizer regions in malignant melanoma and melanotic nevi.
    Leong AS; Gilham P
    Hum Pathol; 1989 Mar; 20(3):257-62. PubMed ID: 2470664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PCNA expression and nucleolar organizer regions in malignant melanoma and nevus cell nevus.
    Kanoko M; Ueda M; Ichihashi M
    Kobe J Med Sci; 1994 Aug; 40(3-4):107-23. PubMed ID: 7739200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silver-stained nucleolar organizer regions (AgNORs) as a prognostic value in malignant melanoma.
    Barzilai A; Goldberg I; Yulash M; Pavlotsky F; Zuckerman A; Trau H; Azizi E; Kopolovic J
    Am J Dermatopathol; 1998 Oct; 20(5):473-7. PubMed ID: 9790108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Argyrophilic nucleolar organizer regions in breast cancer: prognostic significance.
    Kolár Z; Zábranský T; Mattler K; Zábranský E
    Cesk Patol; 1992 Sep; 28(4):193-200. PubMed ID: 1335841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphometric analysis of AgNORs in uveal malignant melanoma.
    Staibano S; Orabona P; Mezza E; Salvatore G; Tranfa F; Capone D; Errico ME; Bonavolontà G; Lucariello A; De Rosa G
    Anal Quant Cytol Histol; 1998 Dec; 20(6):483-92. PubMed ID: 9870100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleolar organizer regions in determining malignancy of pigmented conjunctival lesions.
    Saornil MA; Marcus DM; Doepner D; Apolone G; Torre V; Albert DM
    Am J Ophthalmol; 1993 Jun; 115(6):800-5. PubMed ID: 8506916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Value of nucleolus organizer regions (AgNORs) in dermatologic oncology].
    Pfau A; Eckert F; Schröpfer T; Rüschoff J
    Hautarzt; 1994 Nov; 45(11):762-8. PubMed ID: 7822200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of nucleolar organizer regions in uveal melanoma. The Collaborative Ocular Melanoma Study Group.
    Marcus DM; Minkovitz JB; Wardwell SD; Albert DM
    Am J Ophthalmol; 1990 Nov; 110(5):527-34. PubMed ID: 1700611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of multiple cytometric markers improves discrimination between benign and malignant melanocytic lesions: a study of DNA microdensitometry, karyometry, argyrophilic staining of nucleolar organizer regions and MIB1-Ki67 immunoreactivity.
    Li LX; Crotty KA; Scolyer RA; Thompson JF; Kril JJ; Palmer AA; McCarthy SW
    Melanoma Res; 2003 Dec; 13(6):581-6. PubMed ID: 14646621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleolar organizer regions in benign and malignant glandular lesions of the cervix.
    Allen JP; Gallimore AP
    J Pathol; 1992 Feb; 166(2):153-6. PubMed ID: 1560315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation between the nucleolar organizer region in adenocarcinoma of the prostate and the Gleason system].
    Sentinelli S; Pizzuti V; Rondanelli E; Viggiani F; Paolini R
    Pathologica; 1992; 84(1089):49-55. PubMed ID: 1379709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma and preneoplastic lesions of the liver: evaluation of argyrophilic nucleolar organizer regions (AgNORs).
    Bufo P; Frassanito F
    Boll Soc Ital Biol Sper; 1992 Nov; 68(11):707-14. PubMed ID: 1338418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleolar organizer regions and image analysis nuclear morphometry of small cell (nevoid) melanoma.
    Kossard S; Wilkinson B
    J Cutan Pathol; 1995 Apr; 22(2):132-6. PubMed ID: 7560345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gold toning improves the visualization of nucleolar organizer regions in paraffin embedded tissues.
    Delahunt B; Avallone FA; Ribas JL; Mostofi FK
    Biotech Histochem; 1991; 66(6):316-20. PubMed ID: 1811766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleolar organiser region associated proteins in cutaneous melanotic lesions: a quantitative study.
    Crocker J; Skilbeck N
    J Clin Pathol; 1987 Aug; 40(8):885-9. PubMed ID: 3654987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.